In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
The new site enables end-to-end production of viral vector gene therapies
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Subscribe To Our Newsletter & Stay Updated